Sommaire

• • ·Table of Contents

    Page :A3

    
• • ·Editorial Board

    Page :A8

    
• • ·Information for Authors

    Page :A9

    
• • ·Information for Authors

    Page :A10

    
• • ·Information for Readers

    Page :A11

    
• • ·Author Index

    Page :1215-1236

    
• • ·Subject Index

    Page :1237-1267

    

• Editorial

  • ·Continued improvements in quality improvement research

    Page :1005-1006

    Eric D. Peterson, Mathew T. Roe

    

• Clinical Investigations

  • ·Feasibility and applicability of paramedic-based prehospital fibrinolysis in a large North American center

    Page :1007-1014

    Robert C. Welsh, Andrew Travers, Mano Senaratne, Randall Williams, Paul W. Armstrong

    Résumé Résumé Plan Plan  
  • ·Patterns of use and potential impact of early ?-blocker therapy in non–ST-elevation myocardial infarction with and without heart failure: The Global Registry of Acute Coronary Events

    Page :1015-1021

    Michael Emery, José López-Sendón, Philippe Gabriel Steg, Frederick A. Anderson, Omar H. Dabbous, Aliocha Scheuble, Kim A. Eagle, for the GRACE Investigators

    Résumé Résumé Plan Plan  
  • ·Correction

    Page :1021

    
  • ·Assessment of and physician response to glycemic control in diabetic patients presenting with an acute coronary syndrome

    Page :1022-1027

    Darcy L. Green Conaway, Jonathan R. Enriquez, Jaime E. Barberena, Philip G. Jones, James H. O'Keefe, John A. Spertus

    Résumé Résumé Plan Plan  
  • ·Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery

    Page :1028-1034

    Mary A.M. Rogers, Neil Blumberg, Sanjay K. Saint, Catherine Kim, Brahmajee K. Nallamothu, Kenneth M. Langa

    Résumé Résumé Plan Plan  
  • ·Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States

    Page :1035-1041

    Jing Fang, George A. Mensah, Michael H. Alderman, Janet B. Croft

    Résumé Résumé Plan Plan  
  • ·Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial

    Page :1042-1050

    Harvey D. White, Neal S. Kleiman, Kenneth W. Mahaffey, Yuliya Lokhnygina, Karen S. Pieper, Karen Chiswell, Marc Cohen, Robert A. Harrington, Derek P. Chew, John L. Petersen, Lisa G. Berdan, Philip E.G. Aylward, Christopher C. Nessel, James J. Ferguson, Robert M. Califf

    Résumé Résumé Plan Plan  
  • ·Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus

    Page :1051.e1

    Chao-Hung Wang, Ming-Kuo Ting, Subodh Verma, Li-Tang Kuo, Ning-I Yang, I-Chang Hsieh, Shin-Yi Wang, Agnes Hung, Wen-Jin Cherng

    Résumé Résumé Plan Plan  
  • ·Granulocyte colony stimulating factor in patients with large acute myocardial infarction: Results of a pilot dose-escalation randomized trial

    Page :1051.e9

    Stephen G. Ellis, Marc S. Penn, Brian Bolwell, Mario Garcia, Matthews Chacko, Thomas Wang, Kelly J. Brezina, Gerry McConnell, Eric J. Topol

    Résumé Résumé Plan Plan  
  • ·Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease

    Page :1052-1058

    Nina Johnston, Tomas Jernberg, Bo Lagerqvist, Lars Wallentin

    Résumé Résumé Plan Plan  
  • ·Antihypertensive therapy and regression of coronary artery disease: Insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials

    Page :1059-1063

    Sorin J. Brener, Thomas B. Ivanc, Roman Poliszczuk, Michael Chen, E. Murat Tuzcu, Tingfei Hu, David J. Frid, Steven E. Nissen

    Résumé Résumé Plan Plan  
  • ·Evidence-based cardiovascular therapies and achievement of therapeutic goals in diabetic patients with coronary heart disease attended in primary care

    Page :1064-1070

    Jose M. Mostaza-Prieto, Luís Martín-Jadraque, Isidro López, Salvador Tranche, Carlos Lahoz, Manuel Taboada, Teresa Mantilla, Begoña Soler, Beatriz Monteiro, Miguel Angel Sanchez-Zamorano

    Résumé Résumé Plan Plan  
  • ·B-Type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures

    Page :1071-1076

    Jennifer A. Taylor, Robert H. Christenson, Krishnamurti Rao, Melinda Jorge, Stephen S. Gottlieb

    Résumé Résumé Plan Plan  
  • ·Total cholesterol levels and mortality risk in nonischemic systolic heart failure

    Page :1077-1083

    Nasim Afsarmanesh, Tamara B. Horwich, Gregg C. Fonarow

    Résumé Résumé Plan Plan  
  • ·Short and long-term mortality with nesiritide

    Page :1084-1090

    Rohit R. Arora, Prasanna Kumar Venkatesh, Janos Molnar

    Résumé Résumé Plan Plan  
  • ·Hemoglobin concentration is an independent determinant of heart failure in acute coronary syndromes: cohort analysis of 2310 patients

    Page :1091-1095

    R. Andrew Archbold, Dauda Balami, Abdul Al-Hajiri, Abdel Suliman, Reg Liew, Jackie Cooper, Kulasegarum Ranjadayalan, Charles J. Knight, Andrew Deaner, Adam D. Timmis

    Résumé Résumé Plan Plan  
  • ·Chronic inotropic therapy in end-stage heart failure

    Page :1096.e1

    Paul J. Hauptman, Peter Mikolajczak, Anil George, Clinton J. Mohr, Robert Hoover, Jason Swindle, Mark A. Schnitzler

    Résumé Résumé Plan Plan  
  • ·Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia

    Page :1096.e9

    Alberto Palazzuoli, Donald Silverberg, Francesca Iovine, Stefano Capobianco, Giovanna Giannotti, Anna Calabrò, Stella Maria Campagna, Ranuccio Nuti

    Résumé Résumé Plan Plan  
  • ·Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: The Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study

    Page :1097-1103

    Matthew R. Reynolds, Tara Lavelle, Vidal Essebag, David J. Cohen, Peter Zimetbaum

    Résumé Résumé Plan Plan  
  • ·Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation

    Page :1104-1108

    Peter Leong-Sit, Lorne J. Gula, Pantelis Diamantouros, Andrew D. Krahn, Allan C. Skanes, Raymond Yee, George J. Klein

    Résumé Résumé Plan Plan
  • ·Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke

    Page :1109-1115

    Jingzhong Ding, Barbara J. Nicklas, Margaret D. Fallin, Nathalie de Rekeneire, Stephen B. Kritchevsky, Marco Pahor, Nicolas Rodondi, Rongling Li, Joseph M. Zmuda, Tamara B. Harris

    Résumé Résumé Plan Plan  
  • ·Association of torsades de pointes with novel and known single nucleotide polymorphisms in long QT syndrome genes

    Page :1116-1122

    Amy R. Mank-Seymour, Jodi L. Richmond, Linda S. Wood, Jennifer M. Reynolds, Yu-Ti Fan, Gregory R. Warnes, Patrice M. Milos, John F. Thompson

    Résumé Résumé Plan Plan
  • ·Regression of coronary artery outward remodeling in patients with non–ST-segment acute coronary syndromes: A longitudinal study using noninvasive magnetic resonance imaging

    Page :1123-1132

    Juliano Lara Fernandes, Carlos Vicente Serrano, Maria Heloisa S.L. Blotta, Otavio Rizzi Coelho, Jose Carlos Nicolau, Luis Francisco Ávila, Carlos Eduardo Rochitte, Jose Rodrigues Parga Filho

    Résumé Résumé Plan Plan  
  • ·Ability of mechanical reperfusion to salvage myocardium in patients with acute myocardial infarction presenting beyond 12 hours after onset of symptoms

    Page :1133-1139

    Guido Parodi, Gjin Ndrepepa, Adnan Kastrati, Alberto Conti, Julinda Mehilli, Roberto Sciagrà, Markus Schwaiger, David Antoniucci, Albert Schømig, for the Beyond 12 hours Reperfusion AlternatiVe Evaluation (BRAVE-2) Trial Investigators

    Résumé Résumé Plan Plan
  • ·Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: Subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT)

    Page :1140-1145

    Leif Thuesen, Henning Kelbæk, Lene Kløvgaard, Steffen Helqvist, Erik Jørgensen, Samir Aljabbari, Lars R. Krusell, Gunnar V.H. Jensen, Hans E. Bøtker, Kari Saunamäki, Jens F. Lassen, Anton van Weert, for the SCANDSTENT Investigators Copenhagen, Skejby, and Roskilde, Denmark and Leiden, the Netherlands.

    Résumé Résumé Plan Plan  
  • ·Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry

    Page :1146-1152

    Ralf Zahn, Christian W. Hamm, Steffen Schneider, Uwe Zeymer, Gert Richardt, Malte Kelm, Benny Levenson, Tassilo Bonzel, Ulrich Tebbe, Georg Sabin, Christoph A. Nienaber, Jochen Senges, for the German Cypher Stent Registry

    Résumé Résumé Plan Plan
  • ·The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: One-year results from the Stent or Surgery (SoS) trial

    Page :1153-1160

    Zefeng Zhang, Elizabeth M. Mahoney, John A. Spertus, Jean Booth, Fiona Nugara, Paul Kolm, Rodney H. Stables, William S. Weintraub

    Résumé Résumé Plan Plan  
  • ·Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction

    Page :1161-1167

    Patrick Ohlmann, Laurent Jaquemin, Olivier Morel, Rachid El Behlgiti, Antoine Faure, Marie-Odile Michotey, Nathalie Beranger, Gerald Roul, Francis Schneider, Pierce Bareiss, Jean-Pierre Monassier

    Résumé Résumé Plan Plan  
  • ·Angioscopic evaluation of neointima coverage: Sirolimus drug-eluting stent versus bare metal stent

    Page :1168-1174

    Jota Oyabu, Yasunori Ueda, Nobuyuki Ogasawara, Katsuki Okada, Atsushi Hirayama, Kazuhisa Kodama

    Résumé Résumé Plan Plan  
  • ·Improved adherence to Swedish national guidelines for acute myocardial infarction: The Quality Improvement in Coronary Care (QUICC) study

    Page :1175-1181

    Rickard Carlhed, Mats Bojestig, Lars Wallentin, Gunilla Lindström, Anette Peterson, Christina Åberg, Bertil Lindahl, for the QUICC study group

    Résumé Résumé Plan Plan  
  • ·Evaluation of dyslipidemia in the emergency department: Impact of cholesterol testing on subsequent therapy

    Page :1182-1186

    Andra L. Blomkalns, Elise M. O'Connell, Caroline E. Eady, Christopher J. Lindsell, W. Brian Gibler

    Résumé Résumé Plan Plan
  • ·A randomized controlled trial of women's early use of a novel undergarment following sternotomy: The Women's Recovery from Sternotomy Trial (WREST)

    Page :1187-1193

    Kathryn M. King, Ross Tsuyuki, Peter Faris, Gillian Currie, Andrew Maitland, Ruth L. Collins-Nakai

    Résumé Résumé Plan Plan  
  • ·Trends in postoperative length of stay after bypass surgery

    Page :1194-1200

    Patricia A. Cowper, Elizabeth R. DeLong, Edward L. Hannan, Lawrence H. Muhlbaier, Barbara L. Lytle, Robert H. Jones, William L. Holman, Janel J. Pokorny, Judith A. Stafford, Daniel B. Mark, Eric D. Peterson

    Résumé Résumé Plan Plan  
  • ·Serial radionuclide angiographic assessment of left ventricular ejection fraction and regional wall motion after mitral valve replacement in patients with rheumatic disease

    Page :1201-1207

    Ujjwal K. Chowdhury, Jayanth K.H. Venkataiya, Chetan D. Patel, Sandeep Seth, Rakesh Yadav, Rajvir Singh, Ganapathy K. Subramaniam, Vishwas Malik, Panangipalli Venugopal

    Résumé Résumé Plan Plan  
  • ·Echocardiographic insights into atrial and ventricular mechanisms of functional tricuspid regurgitation

    Page :1208-1214

    Shota Fukuda, A. Marc Gillinov, Jong-Min Song, Masao Daimon, Vorachai Kongsaerepong, James D. Thomas, Takahiro Shiota

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Response to Letter to the Editor by Dr Mackin

    Page :e59

    Charles H. Hennekens, Alissa R. Hennekens, Danielle Hollar, Daniel E. Casey

    
  • ·Cardiology and neurologic family screening in noncompaction

    Page :e61

    Claudia Stöllberger, Josef Finsterer, Gerhard Blazek

    
  • ·Index

    Page :e63

    Rebecca C. Carron, Ann Marie Hart, Richard Naumann